Aperiambio
1 known investors
Aperiam Bio uses computational methods to identify stabilizing mutations in proteins, producing variants with improved expression, solubility, and activity for applications in technical reagents, cosmetics, and pulmonary therapeutics. The company serves partners seeking to manufacture more stable and functional protein-based products across multiple industries.
AI & Machine LearningBiotechDeep Tech